(18)F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results

por Mittlmeier, L. M., Unterrainer, M., Rodler, S., Todica, A., Albert, N. L., Burgard, C., Cyran, C. C., Kunz, W. G., Ricke, J., Bartenstein, P., Stief, C. G., Ilhan, H., Staehler, M.
Publicado 2020

Recent advances of PET imaging in clinical radiation oncology

por Unterrainer, M., Eze, C., Ilhan, H., Marschner, S., Roengvoraphoj, O., Schmidt-Hegemann, N. S., Walter, F., Kunz, W. G., Rosenschöld, P. Munck af, Jeraj, R., Albert, N. L., Grosu, A. L., Niyazi, M., Bartenstein, P., Belka, C.
Publicado 2020

MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial radiotherapy

por Bodensohn, R., Forbrig, R., Quach, S., Reis, J., Boulesteix, A.-L., Mansmann, U., Hadi, I., Fleischmann, D.F., Mücke, J., Holzgreve, A., Albert, N.L., Ruf, V., Dorostkar, M., Corradini, S., Herms, J., Belka, C., Thon, N., Niyazi, M.
Publicado 2022